ENGLISH ABOUT COMPANY SERVICES PRODUCTS QUALITY SERVICE PRESS CENTER CONTACTS COMPANY'S NEWS 03/20/2017 NCPharm participates in IPhEB & CPhi Russia 2017 Biochemist is preparing for the production of innovative Russian drugs EnCiPharm Group of Companies and Access Biosains CJSC have created a joint venture (JV) Peptide Preparations, which will release a number of innovative drugs invented by Russian scientists. PJSC "Biochemist" will be engaged in the industrial production of drugs. The synthesis of substances will also be carried out at this enterprise. Within the framework of the signed agreement, Access Biosains CJSC transfers to the joint venture a portfolio of unique drug developments. In turn, the JV will ensure the conduct of clinical trials within the framework of the state registration of medicines and will be engaged in marketing and promotion of the entire portfolio. “The created joint venture will combine two major competencies - the development of a drug and its launch into industrial production. It is intended to become a vivid example of combining science and practice, "said Dmitry Polyakov, Investment Director of Access Industries. Over the past 10 years, Access Biosains CJSC has made significant investments in domestic research programs in the field of peptide drugs. As a result, Russian scientists have managed to create a number of fundamentally new drugs that are highly effective and safe. Their field of application is the treatment of cardiological, urological and broncho-pulmonary diseases. The product portfolio also includes a unique drug to reduce the negative effects of long-term tobacco use, allowing smokers to get rid of their bad habit in the safest way. Each of the drugs created by Russian scientists is original, has a large amount of scientific trials and studies, is described in scientific monographs, dissertations and other specialized literature. The research results are protected by Russian and international patents. The Biochemist plant will launch the production of these drugs in all therapeutic forms. Reference: PJSC "Biochemist"is one of the most important manufacturers of pharmaceuticals in the Russian Federation and one of the leading industrial enterprises in the Republic of Mordovia. The enterprise was founded in 1959 by the decision of the Council of Ministers of the USSR and has vast experience both in the synthesis of pharmaceutical substances (including antibiotics) and in the production of finished medicinal products. Currently, more than 100 names of medicinal products are produced in ten therapeutic forms, as well as pharmaceutical substances. About 90% of the drugs produced by the enterprise are included in the List of Vital and Essential Medicines (VED). CJSC "Access Biosains"- an enterprise of the Access Industries group of companies - a research and production company established in 2007 to finance developments in the field of peptide biopreparations. This is a fundamentally new class of pharmaceutical products, characterized by high safety, designed to maintain and restore cellular processes in specific tissues of the human body. The results of scientific research are patented in more than 20 countries around the world. HELPFUL INFORMATION Pharmaceutical substances Registration of pharmaceutical substances ISO 9001 CERTIFICATES The Russian company NC Pharm was founded in 1998 and is a leading supplier of raw materials for pharmaceutical substances for domestic drug manufacturers. The only company - a supplier of substances on the Russian market that has received an ISO certificate. © 2010 - 2017 NC Pharm supplier of pharmaceutical substances. All rights to logos and trademarks belong to their respective owners. Tel./Fax: +7 (495) 984 7579 E-mail: info@ncpharm.ru